Effects of ORP, recycling rate, and HRT on simultaneous sulfate reduction and sulfur production in expanded granular sludge bed (EGSB) reactors under micro-aerobic conditions for treating molasses distillery wastewater.

An expanded granular sludge bed (EGSB) reactor was adopted to incubate the sludge biogranule that could simultaneously achieve sulfate reduction and sulfide reoxidization to elemental sulfur for treating molasses distillery wastewater. The EGSB reactor was operated for 175 days at 35 °C with a pH value of 7.0, chemical oxygen demand (COD) loading rate of 4.8 kg COD/(m³ d), and sulfate loading rate of 0.384 kg SO(4)(2-)/(m³ d). The optimal operation parameters, including the oxidation reduction potential (ORP), recycling rate, and hydraulic retention time (HRT), were established to obtain stable and acceptable removal efficiencies of COD, sulfate, and higher elemental sulfur production. With an ORP of -440 mV, a recycling rate of 300%, and HRT of 15 h, the COD and sulfate removal efficiencies were 73.4 and 61.3%, respectively. The elemental sulfur production ratio reached 30.1% when the elemental sulfur concentration in the effluent was 48.1 mg/L. The performance results were also confirmed by the mass balance calculation of sulfate, sulfide, and elemental sulfur over the EGSB reactor.

[Vital pulp therapy of damaged dental pulp].

The development of an expert consensus on vital pulp therapy can provide practical guidance for the improvement of pulp damage care in China. Dental pulp disease is a major type of illness that adversely affects human oral health. Pulp capping and pulpotomy are currently the main methods for vital pulp therapy. Along with the development of minimal invasion cosmetic dentistry, using different treatment technologies and materials reasonably, preserving healthy tooth tissue, and extending tooth save time have become urgent problems that call for immediate solution in dental clinics. This paper summarizes the experiences and knowledge of endodontic experts. We develop a clinical path of vital pulp therapy for clinical work by utilizing the nature, approach, and degree of pulp damage as references, defense and self-repairing ability of pulp as guidance, and modern technologies of diagnosis and treatment as means.

Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.

BACKGROUND: The objective of this study was to identify variables that might interfere with reaching the near final height (NFH) in Congenital adrenal hyperplasia (CAH) due to classic 21-hydroxylase deficiency (21-OHD). METHODS: A cross-sectional study of 82 (24 males and 58 females) classic (23 salt-wasting form [SW] and 59 simple-virilizing form [SV]) CAH 21-OHD patients seen in our institution between 1989 and 2015 with 10.6 (0.5~25.5) years of follow-up who reached their NFH was conducted. The variables related to NFH were explored. RESULTS: NFH (153.35±8.31) cm, (-1.9±1.1) SD was significantly lower than the normal population (p<0.001). The treated patients reached a significantly higher NFH (-1.7±1.1) SD than those untreated (-2.6±1.0) SD (p<0.05). Both of early treatment and late treatment group were taller than untreated group (p<0.001, p=0.013, respectively), and early treatment group had a taller height trend than late treatment group (p=0.089). A better height outcome was observed in patients with advantage in target height, good compliance, and low hydrocortisone dose by multivariate Cox regression analysis in 62 treatment patients. NFH and hydrocortisone dose was negatively correlated (r=-0.23, p=0.078) in treated group. Patients complicated by central precocious puberty (CPP) received gonadotropin-releasing hormone analogue (GnRHa) plus letrozole had increased NFH with height SD for bone age and Ht SD improved after treatment compare to no intervention group (p=0.001, p=0.035). CONCLUSIONS: Patients with classic 21-OHD have blunted final height, as compared with their target height and the population norm, not-treated even worse. Careful treatment adjustments have a favorable influence on growth. Alternative treatments, such as the use of puberty inhibitors GnRHa in addition to anti-estrogen therapy letrozole can somewhat improve NFH in children with 21-OHD complicated by CPP.